熱門資訊> 正文
Equillium股价因RA Capital Management 3500万美元融资而上涨
2026-03-13 20:20
- Equillium (EQ) shares rose 13% premarket after the biotechnology firm secured about $35M in new financing to advance its clinical development of EQ504, an investigational AhR modulator intended to treat ulcerative colitis locally.
- Pursuant to a securities purchase agreement with RA Capital Management, the company will issue around 18.9M shares of its common stock (including shares of common stock underlying pre-funded warrants), representing a purchase price of $1.854 for each share of common stock.
- Equillium intends to use the net proceeds from the financing for further advancement of EQ504, working capital, and general corporate purposes.
- The anticipated net proceeds, along with existing cash and cash equivalents, are expected to extend the cash runway into 2029.
More on Equillium
- Equillium: Multi-Cytokine Platform To Go Beyond Scope Of EQ504 For UC
- Seeking Alpha’s Quant Rating on Equillium
- Historical earnings data for Equillium
- Financial information for Equillium
推薦文章
美股機會日報 | 特朗普再放豪言！正與伊朗談判，並收到伊方「大禮」；特斯拉機器人再迎新進展！馬斯克稱有望明年實現量產
一圖看懂 | 單季盈利承壓！拼多多Q4營收1239億元同比增12%，調后淨利卻下跌12%；高管稱「力爭三年再造一個拼多多」
財報前瞻 | 美團Q4財報將放榜！大摩、高盛逆勢力挺股價，當前美團已嚴重超跌？
中東戰火中金價狂瀉11%！創43年最慘周跌，避險邏輯崩塌還是黃金坑？
美股機會日報 | 中東硝煙將散？以官員稱美方4月9日結束對伊戰爭！海力士擬籌資百億赴美上市，豪擲80億美元鎖定阿斯麥光刻機！
一圖看懂 | 連續5個季度破千億！小米Q4營收1169億創歷史新高；淨利大增43.8%至63億元
無論美伊談判真假！華爾街已從特朗普引發的五分鍾狂飆獲得明確信號？
麥格理：緊張局勢緩和后布倫特原油底部在每桶85至90美元
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
